Pacific Biosciences Of California Gross Profit 2010-2024 | PACB

Pacific Biosciences Of California gross profit from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Pacific Biosciences Of California Annual Gross Profit
(Millions of US $)
2023 $53
2022 $49
2021 $59
2020 $33
2019 $35
2018 $25
2017 $35
2016 $44
2015 $53
2014 $23
2013 $6
2012 $1
2011 $13
2010 $2
2009 $0
Pacific Biosciences Of California Quarterly Gross Profit
(Millions of US $)
2024-09-30 $10
2024-06-30 $6
2024-03-31 $11
2023-12-31 $10
2023-09-30 $18
2023-06-30 $16
2023-03-31 $10
2022-12-31 $5
2022-09-30 $14
2022-06-30 $16
2022-03-31 $14
2021-12-31 $17
2021-09-30 $15
2021-06-30 $14
2021-03-31 $13
2020-12-31 $11
2020-09-30 $7
2020-06-30 $7
2020-03-31 $7
2019-12-31 $13
2019-09-30 $7
2019-06-30 $10
2019-03-31 $5
2018-12-31 $6
2018-09-30 $3
2018-06-30 $9
2018-03-31 $7
2017-12-31 $9
2017-09-30 $8
2017-06-30 $8
2017-03-31 $9
2016-12-31 $11
2016-09-30 $13
2016-06-30 $11
2016-03-31 $10
2015-12-31 $26
2015-09-30 $7
2015-06-30 $15
2015-03-31 $6
2014-12-31 $4
2014-09-30 $13
2014-06-30 $3
2014-03-31 $3
2013-12-31 $3
2013-09-30 $1
2013-06-30 $1
2013-03-31 $1
2012-12-31 $1
2012-09-30 $0
2012-06-30 $0
2012-03-31 $-0
2011-12-31 $2
2011-09-30 $3
2011-06-30 $8
2011-03-31 $0
2010-12-31 $0
2010-09-30 $0
2010-06-30 $1
2010-03-31 $1
2009-12-31
2009-09-30
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.501B $0.201B
Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $204.416B 24.94
Intuitive Surgical (ISRG) United States $192.946B 100.88
Alcon (ALC) Switzerland $43.080B 28.83
Edwards Lifesciences (EW) United States $41.404B 26.29
IQVIA Holdings (IQV) United States $36.405B 20.06
IDEXX Laboratories (IDXX) United States $35.383B 41.67
DexCom (DXCM) United States $31.603B 47.59
Waters (WAT) United States $22.979B 33.98
STERIS (STE) Ireland $21.385B 24.62
SONOVA HOLDING (SONVY) Switzerland $19.978B 0.00
Hologic (HOLX) United States $17.581B 18.99
Fresenius Medical Care AG KGaA (FMS) Germany $13.691B 14.05
Sysmex ADR (SSMXY) Japan $13.362B 41.90
Globus Medical (GMED) United States $11.588B 29.34
Penumbra (PEN) United States $9.412B 92.19
Masimo (MASI) United States $9.326B 45.13
Teleflex (TFX) United States $8.737B 13.94
Glaukos (GKOS) United States $7.499B 0.00
PROCEPT BioRobotics (PRCT) United States $5.035B 0.00
Integer Holdings (ITGR) United States $4.735B 26.84
Veracyte (VCYT) United States $3.384B 101.54
Inari Medical (NARI) United States $3.018B 0.00
LivaNova (LIVN) United Kingdom $2.803B 16.18
Nihon Kohden (NHNKY) Japan $2.421B 18.39
TransMedics (TMDX) United States $2.398B 76.00
Tandem Diabetes Care (TNDM) United States $2.192B 0.00
Elekta AB (EKTAY) Sweden $2.121B 19.07
Integra LifeSciences Holdings (IART) United States $1.901B 9.93
RxSight (RXST) United States $1.756B 0.00
Alphatec Holdings (ATEC) United States $1.418B 0.00
Pulse Biosciences (PLSE) United States $1.248B 0.00
Artivion (AORT) United States $1.244B 82.44
OPKO Health (OPK) United States $1.078B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.875B 14.87
Paragon 28 (FNA) United States $0.856B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.739B 0.00
IRadimed (IRMD) United States $0.680B 36.74
Mesa Laboratories (MLAB) United States $0.668B 15.75
AxoGen (AXGN) United States $0.635B 0.00
OrthoPediatrics (KIDS) United States $0.634B 0.00
SiBone (SIBN) United States $0.546B 0.00
Treace Medical Concepts (TMCI) United States $0.533B 0.00
Semler Scientific (SMLR) United States $0.527B 31.04
Tactile Systems Technology (TCMD) United States $0.453B 24.53
Delcath Systems (DCTH) United States $0.379B 0.00
CVRx (CVRX) United States $0.365B 0.00
NeuroPace (NPCE) United States $0.356B 0.00
ClearPoint Neuro (CLPT) United States $0.331B 0.00
AngioDynamics (ANGO) United States $0.289B 0.00
Inogen (INGN) United States $0.237B 0.00
Accuray (ARAY) United States $0.211B 0.00
Alpha Tau Medical (DRTS) Israel $0.210B 0.00
Sight Sciences (SGHT) United States $0.196B 0.00
KORU Medical Systems (KRMD) United States $0.182B 0.00
Nevro (NVRO) United States $0.160B 0.00
Atossa Genetics (ATOS) United States $0.155B 0.00
Sensus Healthcare (SRTS) United States $0.141B 15.05
Spectral Diagnostics (EDTXF) Canada $0.116B 0.00
908 Devices (MASS) United States $0.092B 0.00
EDAP TMS S.A (EDAP) France $0.091B 0.00
LENSAR (LNSR) United States $0.089B 0.00
Vicarious Surgical (RBOT) United States $0.088B 0.00
WORK Medical Technology Group (WOK) China $0.087B 0.00
Monogram Orthopaedics (MGRM) United States $0.080B 0.00
InspireMD (NSPR) Israel $0.079B 0.00
Covalon Technologies (CVALF) Canada $0.074B 0.00
Hyperfine (HYPR) United States $0.073B 0.00
Lucid Diagnostics (LUCD) United States $0.057B 0.00
EnVVeno Medical (NVNO) United States $0.053B 0.00
Rapid Micro Biosystems (RPID) United States $0.045B 0.00
Envoy Medical (COCH) United States $0.044B 0.00
Spectral AI (MDAI) United States $0.041B 0.00
Accelerate Diagnostics (AXDX) United States $0.039B 0.00
Adagio Medical Holdings (ADGM) United States $0.036B 0.00
Neuronetics (STIM) United States $0.035B 0.00
Precision Optics (POCI) United States $0.032B 0.00
Biosig Technologies (BSGM) United States $0.029B 0.00
DarioHealth (DRIO) United States $0.026B 0.00
NexGel (NXGL) United States $0.024B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
Ekso Bionics Holdings (EKSO) United States $0.015B 0.00
Baird Medical Investment Holdings (BDMD) $0.015B 0.00
Aspira Women's Health (AWH) United States $0.014B 0.00
PAVmed (PAVM) United States $0.013B 0.00
T2 Biosystems (TTOO) United States $0.011B 0.00
QT Imaging Holdings (QTI) United States $0.010B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Autonomix Medical (AMIX) United States $0.005B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00